-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.P1.39 723. Allogeneic Transplantation: Long-Term Follow-Up and Disease Recurrence: Poster I

Symposia: Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Asahito Hama1*, Nao Yoshida, MD, PhD1*, Daisuke Hasegawa, MD, PhD2*, Motohiro Kato, MD, PhD3*, Kenichiro Watanabe, MD, PhD4*, Daiichiro Hasegawa, MD, PhD5, Tetsuya Nishida, MD, PhD6*, Noriko Doki, MD, PhD7, Maho Sato, MD, PhD8*, Yasushi Onishi, MD, PhD9*, Takuro Nishikawa, MD, PhD10*, Hiroshi Tujimoto, MD, PhD11*, Katsuyoshi Koh, MD, PhD12*, Tetsuya Mori, MD, PhD13*, Koji Kato, MD, PhD14*, Yoshiko Hashii, MD, PhD15, Atsushi Sato, MD, PhD16*, Ken Tabuchi, MD, PhD17*, Jun Aoki, MD, PhD18* and Shohei Yamamoto, MD, PhD19*

1Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, JPN
2Department of Pediatrics, St. Luke's International Hospital, Tokyo, JPN
3Department of Pediatrics, Tokyo University, Tokyo, JPN
4Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, SHZ, JPN
5Hematology and Oncology,, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan
6Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
8Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, JPN
9Department of Hematology, Tohoku University Hospital, Sendai, Japan
10Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Hospital, Kagoshima, JPN
11Department of Pediatrics, Wakayama Medical University, Wakayama, Japan
12Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
13Department of Pediatrics, St. Marianna University School of Medicine, Kanagawa, JPN
14Central Japan Cord Blood Bank, Seto, JPN
15Department of Pediatrics, Osaka International Cancer Institute, Osaka, JPN
16Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan
17Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
18Department of Hematology, Kanto Rosai Hospital, Kawasaki, Japan
19Department of Pediatrics, Tokai University Hospital, Isehara, JPN

Hermioni L Amonoo, MD1,2,3, Michelle Guo, MD2*, Elizabeth Daskalakis, BA2*, Emma Deary, BA2*, Stephanie J. Lee4, Thomas W LeBlanc, MD5, Jeff C. Huffman, MD6* and Areej El-Jawahri, MD6

1Harvard Medical School, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
4Fred Hutchinson Cancer Center, Seattle, WA
5Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
6Massachusetts General Hospital, Boston, MA

Shokichi Tsukamoto, MD, PhD1, Kenji Kimura, MD, PhD2*, Sanshiro Nakao, MD, PhD1*, Yusuke Takeda, MD, PhD1*, Chikako Ohwada, MD, PhD1,3, Ryo Shimizu, MD, PhD4*, Yuhei Nagao, MD, PhD2*, Katsuhiro Shono, MD, PhD2*, Masahiro Onoda, MD, PhD2*, Akira Yokota, MD, PhD2*, Hironori Arai, MD5*, Yoshikazu Utsu, MD5*, Shinichi Masuda, MD, PhD6*, Nobuyuki Aotsuka, MD, PhD5*, Yuki Shiko7*, Yoshihito Ozawa7*, Arata Ishii, MD, PhD1*, Shinichiro Matsui, MD, PhD8*, Koji Takaishi, MD, PhD1*, Yutaro Hino, MD, PhD1*, Kensuke Kayamori1*, Nagisa Oshima-Hasegawa, MD, PhD1*, Shio Mitsukawa, MD, PhD9*, Tomoya Muto, MD, PhD1*, Naoya Mimura, MD, PhD9, Chiaki Nakaseko, MD, PhD3 and Emiko Sakaida, MD, PhD1

1Department of Hematology, Chiba University Hospital, Chiba, Japan
2Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
3Department of Hematology, International University of Health and Welfare School of Medicine, Narita, Japan
4Department of Hematology, Asahi General Hospital, Asahi, Japan
5Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan
6Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan
7Clinical Reserch Center, Chiba University Hospital, Chiba, Japan
8Department of Hematology, Chiba University Hospital, Chiba-Shi, Japan
9Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan

Maryam Rafati, MD, PhD1*, Lisa J. McReynolds, MD, PhD2, Youjin Wang1*, Casey Dagnall3*, Belynda Hicks3*, Kristine Jones4*, Stephen R. Spellman, MBS5*, Meilun He, MPH6*, Yung-Tsi Bolon, PhD6*, Stephanie J. Lee7, Sharon A Savage, MD1 and Shahinaz M. Gadalla, MD, PhD1

1Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD
2National Cancer Institute, Rockville, MD
3CancerGenomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville
4Leidos Biomedical, Inc., Gaithersburg, MD
5CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
6CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis
7University of Washington, Seattle, WA

Elizabeth Kathryn Herrity, CNP1,2*, Tommy Alfaro, MD1,2*, Mariana Pinto Pereira, MD1,2*, Igor Novitzky-Basso, MD1,2*, Wilson Lam, MD1,2, Ivan Pasic, MD1,2*, Fotios Michelis, MD, PhD1,2*, Arjun D. Law, MD1,2*, Auro Viswabandya, MD2,3, Adam Smith, PhD1,2*, Anne Maria Tierens, MD, PhD1,2, Armin Gerbitz, MD, PhD1,2*, Rajat Kumar, MD, FRCPC2,3, Jonas Mattsson, MD, PhD2,4* and Dennis D. H. Kim1,2

1Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada
2University of Toronto, Toronto, Canada
3Princess Margaret Cancer Centre, Toronto, Canada
4Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, Toronto, Canada

Ayman Sayyed, BMBS, MRCP1*, Hyewon Lee2*, Taehyung Simon Kim2*, Jaeyoon John Kim2*, Danielle Pyne2*, Nathali Kaushansky, PhD3*, Yardena Brilon3*, Noa Chapal-Ilani3*, Tamir Biezuner3*, Liran I. Shlush, MD, PhD3*, Jan Storek, MD, PhD4 and Dennis Dong Hwan Kim, MD, PhD2

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Riyadh, Saudi Arabia
2Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
4The University of Calgary Department of Medicine, Calgary, Canada

Sina Alexandra Beer, MD*, Johanna Blaettel*, Kristina Reuss, MD*, Jan Christian Schröder, MD*, Wichard Vogel, MD*, Christoph Faul, MD, Wolfgang Andreas Bethge, MD* and Claudia Lengerke, MD

Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany

Ioannis Politikos, MD1,2, Warren B Fingrut, MD2, Samantha Brown3*, Stephanie Chinapen4*, Sean Quach, BSc5*, Parastoo B. Dahi, MD6,7*, Boglarka Gyurkocza, MD2,7, Ann A. Jakubowski, MD, PhD8, Esperanza B. Papadopoulos, MD2,7, Doris M. Ponce, MD, MS7,9, Roni Tamari, MD2, Miguel-Angel Perales, MD2,10, Andromachi Scaradavou, MD11 and Juliet N Barker, MBBS1

1Department of Medicine, Weill Cornell Medicine, New York
2Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
5Memorial Sloan Kettering Cancer Center, New York
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine, Weill Cornell Medical College, New York, NY
8Memorial Sloan-Kettering Cancer Ctr., New York, NY
9Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
10Department of Medicine, Weill Cornell Medical College, New York
11Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY

Jong Hyuk Lee, MD1*, Jae-Ho Yoon, MD2, Daehun Kwag3*, Gi-June Min2*, Sung-Soo Park2*, Silvia Park4*, Sung-Eun Lee, MD5*, Byung-Sik Cho2*, Ki-Seong Eom2*, Yoo-Jin Kim2, Heeje Kim, MD, PhD6, Chang-Ki Min2*, Seok-Goo Cho2*, Jong-Wook Lee, MD7 and Seok Lee2

1Department of Hematology, Incheon St.Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, Th, Seoul, South Korea
4Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
5Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
6Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea

Michael Radford, MD, BSc1*, Alejandro Garcia-Horton, MD2, Rohail Badami3*, Elaine Jin4*, Nida Javed Usmani, MBBS5*, Daria Grafodatskaya6,7*, Elizabeth McCready, PhD6,8*, Dina Khalaf, MSc, MBBS9, Irwin Walker, MBBS9, Brian Leber, MD10, Kylie L. Lepic, MD9*, Gregory Pond11,12* and Tobias Berg, MD2,13,14

1Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada
2Department of Oncology, McMaster University, Hamilton, ON, Canada
3Department of Interdisciplinary Science, McMaster University, Hamilton, ON, Canada
4Department of Medicine, McMaster University, Hamilton, ON, Canada
5CHU St Justine, Montreal, QC, CAN
6Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
7Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, ON, Canada
8Genetic Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton Health Science, Hamilton, ON, Canada
9Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
10Division of Hematology, Juravinski Cancer Center, Hamilton, ON, Canada
11Juravinski Cancer Center, Hamilton, ON, Canada
12Escarpment Cancer Research Institute, McMaster University, Hamilton, ON, Canada
13Escarpment Cancer Research Institute, Hamilton Health Sciences / McMaster University, Hamilton, ON, Canada
14Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada

Zhihui Li1*, Teng Xu2*, Xianxuan Wang1*, Xiaopei Wen1*, Lei Wang1*, Jingjing Wang1* and Tong Wu, MD3

1Department of Bone Marrow Transplantation, Beijing Gaobo Boren Hospital, Beijing, China
2Department of Data Management, Beijing Gaobo Boren Hospital, Beijing, China
3Department of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing, China

Ka Young Kim, MD1*, Daehun Kwag2*, Gi-June Min2*, Sung-Soo Park2*, Silvia Park1*, Jae-Ho Yoon, MD2, Sung-Eun Lee, MD3*, Ki-Seong Eom2*, Yoo-Jin Kim2, Seok Lee2, Chang-Ki Min2*, Seok-Goo Cho2*, Jong-Wook Lee, MD4, Byung-Sik Cho2* and Heeje Kim, MD, PhD5

1Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
4Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea
5Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

*signifies non-member of ASH